Sanj K Patel
CIK 1532218 · CHAIRMAN & CEO · last filed 2026-06-02
Sanj K Patel is a CHAIRMAN & CEO who has filed 68 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for KNSA, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$71.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $49.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$49.39M
5
68
-$71.47M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KNSA | CHAIRMAN & CEO | 951,794 | $51.89 | $49.39M | -$30.28M | 42 | 2026-06-02 |
| SYRS | Director | — | $0.00 | — | $0 | 3 | 2017-09-22 |
| BCRX | Director | — | $8.70 | — | $0 | 3 | 2017-05-25 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | President & CEO | 0 | — | — | -$41.19M | 19 | 2015-06-23 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 452 | $19.00 | $8.6K | $0 | 1 | 2014-07-21 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | KNSA | Conv (C) | +900,000 | $0 | EDGAR |
| 2026-05-01 | KNSA | Mixed | — | -$1.12M | EDGAR |
| 2026-04-08 | KNSA | Mixed | +5,160 | -$525.0K | EDGAR |
| 2026-04-03 | KNSA | Mixed | +11,014 | -$496.4K | EDGAR |
| 2025-11-14 | KNSA | Gift (G) | — | $0 | EDGAR |
| 2025-10-22 | KNSA | Mixed | — | -$9.04M | EDGAR |
| 2025-09-03 | KNSA | Mixed | +15,120 | -$476.7K | EDGAR |
| 2025-05-28 | KNSA | Mixed | — | -$2.21M | EDGAR |
| 2025-05-22 | KNSA | Mixed | — | -$59.7K | EDGAR |
| 2025-05-15 | KNSA | Mixed | — | -$73.1K | EDGAR |